Vice President, Quality Assurance

The Vice President, Quality Affairs is responsible for establishing and maintaining the Company’s global pharmaceutical quality

system and providing independent Quality oversight across its product portfolio and external GxP network. This role ensures that

clinical and commercial activities are conducted in accordance with applicable global regulations, cGxP requirements, regulatory

commitments, and Company standards while supporting the Company’s strategic and operational objectives.

Operating within a fully outsourced model, the Vice President provides executive Quality leadership for product disposition,

external partner oversight, quality-system governance, regulatory inspections, and the identification and management of

significant quality and compliance risks. The role has the authority to escalate quality concerns, reject product, and suspend

regulated activities when necessary to protect patients, product quality, data integrity, or regulatory compliance.

• Lead the development, implementation, governance, and continuous improvement of the Company’s pharmaceutical quality system,

including management review, document control, training, change control, deviations, investigations, CAPAs, complaints, and

product-quality review.

• Provide independent Quality oversight of clinical and commercial manufacturing, testing, packaging, labeling, storage, and

distribution activities performed by external partners.

• Serve as the Company’s final Quality authority for batch disposition and release within delegated responsibilities, while

ensuring compliance with market-specific requirements, including Qualified Person certification where required.

• Ensure timely, risk-based review and approval of batch records, analytical results, deviations, investigations, change

controls, CAPAs, specifications, validation documentation, and other records affecting product quality or disposition.

• Provide Quality oversight of process and analytical changes, technology transfers, validation activities, new product

introductions, product acquisitions, and post-approval changes.

• Establish and maintain a risk-based lifecycle program for qualifying, auditing, monitoring, and requalifying CDMOs, contract

laboratories, packagers, distributors, and other GxP suppliers.

• Establish quality agreements and governance processes that clearly define responsibilities, communication requirements,

performance expectations, and escalation pathways with external partners.

• Monitor internal and external quality performance through meaningful metrics, management review, trend analysis, and partner

governance; ensure significant risks and adverse trends are appropriately escalated and addressed.

• Lead regulatory inspection readiness and serve as the primary Quality representative during inspections and health-authority

interactions. Oversee the development and completion of inspection responses and remediation commitments.

• Ensure appropriate oversight of data integrity, electronic records, computerized systems, and documentation practices within

the Company and across its external GxP network.

• Lead or support critical quality events, including significant investigations, product-quality complaints, recalls, market

actions, and regulatory notifications.

• Provide Quality expertise for business-development due diligence, licensing activities, product acquisitions,

investigator-initiated studies, and promotional review, as applicable to the Company’s procedures and the role’s assigned

scope.

• Develop and manage the Quality Affairs budget, organizational capabilities, resource plans, and external support required to

meet portfolio and corporate objectives.

• Build and lead a high-performing Quality organization while fostering a culture of quality, accountability, compliance,

transparency, and continuous improvement across the Company.

• Bachelor’s degree in chemical engineering, pharmaceutical sciences, chemistry, biochemistry, biology, or a related scientific

or engineering discipline; an advanced degree is preferred.

• At least 15 years of progressively responsible Quality experience within the pharmaceutical or biotechnology industry,

including significant leadership responsibility for commercial products.

• Demonstrated experience leading Quality in a fully or substantially outsourced operating model, with oversight of CDMOs,

contract laboratories, packaging and labeling providers, distributors, and other GxP suppliers.

• Broad experience across multiple product modalities and manufacturing platforms. Experience with at least two of the following

is strongly preferred: oral solid dosage forms, biologics, and oligonucleotide products.

• Extensive experience with batch disposition, pharmaceutical quality systems, supplier quality, investigations, change control,

CAPA, validation oversight, product complaints, and inspection readiness.

• Strong knowledge of applicable global GMP and GDP requirements, including 21 CFR Parts 210 and 211, relevant EU regulations and

GMP guidance, ICH guidelines, and applicable FDA and EMA expectations.

• Experience interacting directly with regulatory authorities and successfully leading regulatory inspections, responses,

remediation activities, and compliance commitments.

• Demonstrated ability to make independent, risk-based product-quality and compliance decisions using sound scientific and

regulatory judgment.

• Experience leading managers and professional staff and establishing effective Quality governance across cross-functional and

external-partner organizations.

• Strong executive presence and the ability to communicate complex quality risks, recommendations, and decisions clearly to

senior leadership, boards, regulators, partners, and technical teams.

• Excellent leadership, negotiation, organizational, analytical, and problem-solving skills, with the ability to manage multiple

priorities in a dynamic environment.

As a global organization, we are open to considering candidates in multiple locations. The position can be based either at our

Stockholm, Sweden office or at our Cary, North Carolina office, depending on the selected candidate and the position reports to

the Senior Vice President and Head of Pharmaceutical Operations & Technologies.

The Asahi Kasei Group operates with a commitment of creating for tomorrow. Our business sectors, Material, Homes, and Health Care,

contribute to the development of society by anticipating the changing needs of those around the world. We look for candidates that

offer a fresh perspective and a variety of skills to help us achieve our commitment.

Calliditas’ lead product, developed under the name Nefecon, has received full approval by the FDA under the trade name TARPEYO®

and by the European Commission under the trade name KINPEYGO®. TARPEYO/KINPEYGO® is the first treatment approved for IgA

nephropathy by the FDA and EMA, respectively.